Elbit Med Tech (EMTC) - Total Liabilities

Latest as of December 2022: ILA522.00K ILA ≈ $1.40K USD

Based on the latest financial reports, Elbit Med Tech (EMTC) has total liabilities worth ILA522.00K ILA (≈ $1.40K USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore EMTC cash generation efficiency to assess how effectively this company generates cash.

Elbit Med Tech - Total Liabilities Trend (2008–2022)

This chart illustrates how Elbit Med Tech's total liabilities have evolved over time, based on quarterly financial data. Check EMTC financial resilience to evaluate the company's liquid asset resilience ratio.

Elbit Med Tech Competitors by Total Liabilities

The table below lists competitors of Elbit Med Tech ranked by their total liabilities.

Company Country Total Liabilities
Tasfoods Ltd
AU:TFL
Australia AU$18.89 Million
Frontier Developments Plc
LSE:FDEV
UK GBX35.53 Million
Smartfren Telecom Tbk
JK:FREN
Indonesia Rp21.74 Trillion
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
USA $608.34 Million
Ortin Global Limited
NSE:ORTINGLOBE
India Rs25.26 Million
Fuse Cobalt Inc
V:FUSE
Canada CA$166.95K

Liability Composition Analysis (2008–2022)

This chart breaks down Elbit Med Tech's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EMTC market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.02 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.02 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Elbit Med Tech's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Elbit Med Tech (2008–2022)

The table below shows the annual total liabilities of Elbit Med Tech from 2008 to 2022.

Year Total Liabilities Change
2022-12-31 ILA522.00K
≈ $1.40K
-7.45%
2021-12-31 ILA564.00K
≈ $1.51K
-98.47%
2020-12-31 ILA36.97 Million
≈ $99.12K
-26.77%
2019-12-31 ILA50.48 Million
≈ $135.34K
+15.99%
2018-12-31 ILA43.52 Million
≈ $116.69K
+2.47%
2017-12-31 ILA42.48 Million
≈ $113.87K
+14.23%
2016-12-31 ILA37.18 Million
≈ $99.69K
+9.35%
2015-12-31 ILA34.00 Million
≈ $91.16K
+4.42%
2014-12-31 ILA32.56 Million
≈ $87.31K
-3.70%
2013-12-31 ILA33.82 Million
≈ $90.66K
-41.03%
2011-12-31 ILA57.35 Million
≈ $153.75K
+65.68%
2010-12-31 ILA34.61 Million
≈ $92.80K
-78.13%
2009-12-31 ILA158.28 Million
≈ $424.35K
-14.28%
2008-12-31 ILA184.65 Million
≈ $495.03K
--

About Elbit Med Tech

TA:EMTC Israel Healthcare Equipment & Supplies
Market Cap
$5.52 Million
ILA2.06 Billion ILA
Market Cap Rank
#30020 Global
#446 in Israel
Share Price
ILA22.20
Change (1 day)
-7.50%
52-Week Range
ILA18.20 - ILA29.60
All Time High
ILA185.50
About

Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of magnetic and focused imaging equipment in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurologica… Read more